Immutep Ltd (IMM) has received a A$1,910,010 cash rebate from the French Government under its Crédit d’Impôt Recherche (CIR) scheme, a tax incentive by which French companies - Immutep qualifies to receive CIR credits through its subsidiary Immutep S.A.S. - conducting research and development activities in Europe can be reimbursed 30% of their eligible expenditure. The funds will be used to support the ongoing and planned global clinical development of eftilagimod alpha and the preclinical development of IMP761
http://crweworld.com/article/news-p...nt-related-tax-rebate-from-french-government-
Ann: Immutep receives A$1.9M from French R&D tax cash rebate, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.020(6.06%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.3¢ | 30.5¢ | $1.905M | 6.153M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 13147 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 101130 | 2 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
